AG
ELV icon

Advisor Group’s Elevance Health ELV Stock Holding History

Advisor Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5.01M Sell
16,580
-8,500
-34% -$2.34M 0.03% 420
2019
Q3 		$6.02M Buy
25,080
+2,419
+11% +$663K 0.04% 360
2019
Q2 		$6.4M Buy
22,661
+2,554
+13% +$698K 0.05% 318
2019
Q1 		$5.77M Buy
20,107
+7,757
+63% +$2.24M 0.05% 334
2018
Q4 		$3.25M Buy
12,350
+1,001
+9% +$275K 0.03% 443
2018
Q3 		$3.11M Buy
11,349
+1,703
+18% +$442K 0.03% 481
2018
Q2 		$2.3M Sell
9,646
-737
-7% -$171K 0.03% 501
2018
Q1 		$2.28M Buy
10,383
+2,728
+36% +$641K 0.03% 511
2017
Q4 		$1.72M Buy
7,655
+2,328
+44% +$496K 0.02% 616
2017
Q3 		$1.01M Sell
5,327
-407
-7% -$77.5K 0.02% 794
2017
Q2 		$1.08M Buy
5,734
+1,263
+28% +$227K 0.02% 721
2017
Q1 		$741K Buy
4,471
+2,074
+87% +$330K 0.02% 869
2016
Q4 		$345K Sell
2,397
-503
-17% -$67.4K 0.01% 1222
2016
Q3 		$363K Sell
2,900
-328
-10% -$42.4K 0.01% 1156
2016
Q2 		$421K Buy
+3,228
New +$442K 0.01% 1009

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

Advisor Group's ELV Position: Q4 2019 in Review

Advisor Group reduced its Elevance Health (ELV) stake by 34% in Q4 2019, selling an estimated $2.34M and leaving 16,580 shares worth $5.01M. The position accounts for 0.03% of the portfolio, ranked #420.

Advisor Group first reported a position in ELV in Q2 2016 and has held it in 15 quarters since. The position peaked at $6.4M in Q2 2019. 1,112 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Advisor Group held 16,580 shares of Elevance Health worth $5.01M as of Q4 2019.
  • Advisor Group sold 8,500 Elevance Health shares in Q4 2019, an estimated $2.34M.
  • Elevance Health made up 0.03% of Advisor Group's portfolio in Q4 2019, its #420 holding.
  • Advisor Group first reported a position in Elevance Health in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Elevance Health position peaked at $6.4M in Q2 2019.
  • 1,112 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.